{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T11:09:32Z","timestamp":1779361772899,"version":"3.51.4"},"publisher-location":"Cham","reference-count":152,"publisher":"Springer Nature Switzerland","isbn-type":[{"value":"9783032214140","type":"print"},{"value":"9783032214157","type":"electronic"}],"license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026]]},"DOI":"10.1007\/978-3-032-21415-7_14","type":"book-chapter","created":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T10:10:59Z","timestamp":1779358259000},"page":"975-1000","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Molecular Imaging in Photon Radiotherapy"],"prefix":"10.1007","author":[{"given":"Sonja","family":"Adebahr","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jamina Tara","family":"Fennell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eleni","family":"Gkika","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anca L.","family":"Grosu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,5,22]]},"reference":[{"key":"14_CR1","first-page":"3197","volume":"9","author":"F Zhao","year":"2016","unstructured":"Zhao F, Li M, Kong L, Zhang G, Yu J (2016) Delineation of radiation therapy target volumes for patients with postoperative glioblastoma: a review. Onco Targets Ther 9:3197\u20133204","journal-title":"Onco Targets Ther"},{"key":"14_CR2","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1038\/ncponc1041","volume":"5","author":"WA Weber","year":"2008","unstructured":"Weber WA, Grosu AL, Czernin J (2008) Technology Insight: advances in molecular imaging and an appraisal of PET\/CT scanning. Nat Clin Pract Oncol 5:160\u2013170","journal-title":"Nat Clin Pract Oncol"},{"key":"14_CR3","doi-asserted-by":"publisher","first-page":"91","DOI":"10.3389\/fonc.2014.00091","volume":"4","author":"ML Nguyen","year":"2014","unstructured":"Nguyen ML, Willows B, Khan R, Chi A, Kim L, Nour SG, Sroka T, Kerr C, Godinez J, Mills M, Karlsson U, Altdorfer G, Nguyen NP, Jendrasiak G, International Geriatric Radiotherapy G (2014) The potential role of magnetic resonance spectroscopy in image-guided radiotherapy. Front Oncol 4:91","journal-title":"Front Oncol"},{"key":"14_CR4","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/j.ijrobp.2012.01.020","volume":"84","author":"DB Einstein","year":"2012","unstructured":"Einstein DB, Wessels B, Bangert B, Fu P, Nelson AD, Cohen M, Sagar S, Lewin J, Sloan A, Zheng Y, Williams J, Colussi V, Vinkler R, Maciunas R (2012) Phase II trial of radiosurgery to magnetic resonance spectroscopy-defined high-risk tumor volumes in patients with glioblastoma multiforme. Int J Radiat Oncol Biol Phys 84:668\u2013674","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"14_CR5","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1186\/s12885-019-5317-x","volume":"19","author":"A Laprie","year":"2019","unstructured":"Laprie A, Ken S, Filleron T, Lubrano V, Vieillevigne L, Tensaouti F, Catalaa I, Boetto S, Khalifa J, Attal J, Peyraga G, Gomez-Roca C, Uro-Coste E, Noel G, Truc G, Sunyach MP, Magne N, Charissoux M, Supiot S, Bernier V, Mounier M, Poublanc M, Fabre A, Delord JP, Cohen-Jonathan Moyal E (2019) Dose-painting multicenter phase III trial in newly diagnosed glioblastoma: the SPECTRO-GLIO trial comparing arm A standard radiochemotherapy to arm B radiochemotherapy with simultaneous integrated boost guided by MR spectroscopic imaging. BMC Cancer 19:167","journal-title":"BMC Cancer"},{"key":"14_CR6","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1016\/j.ijrobp.2010.07.002","volume":"81","author":"AL Grosu","year":"2011","unstructured":"Grosu AL, Astner ST, Riedel E, Nieder C, Wiedenmann N, Heinemann F, Schwaiger M, Molls M, Wester HJ, Weber WA (2011) An interindividual comparison of O-(2-[18F]fluoroethyl)-L-tyrosine (FET)- and L-[methyl-11C]methionine (MET)-PET in patients with brain gliomas and metastases. Int J Radiat Oncol Biol Phys 81:1049\u20131058","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"14_CR7","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1007\/s002590050541","volume":"27","author":"WA Weber","year":"2000","unstructured":"Weber WA, Wester HJ, Grosu AL, Herz M, Dzewas B, Feldmann HJ, Molls M, Stocklin G, Schwaiger M (2000) O-(2-[18F]fluoroethyl)-L-tyrosine and L-[methyl-11C]methionine uptake in brain tumours: initial results of a comparative study. Eur J Nucl Med 27:542\u2013549","journal-title":"Eur J Nucl Med"},{"key":"14_CR8","doi-asserted-by":"publisher","first-page":"207","DOI":"10.2967\/jnumed.111.096859","volume":"53","author":"V Dunet","year":"2012","unstructured":"Dunet V, Rossier C, Buck A, Stupp R, Prior JO (2012) Performance of 18F-fluoro-ethyl-tyrosine (18F-FET) PET for the differential diagnosis of primary brain tumor: a systematic review and Metaanalysis. J Nucl Med 53:207\u2013214","journal-title":"J Nucl Med"},{"key":"14_CR9","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.radonc.2010.08.001","volume":"96","author":"AL Grosu","year":"2010","unstructured":"Grosu AL, Weber WA (2010) PET for radiation treatment planning of brain tumours. Radiother Oncol 96:325\u2013327","journal-title":"Radiother Oncol"},{"key":"14_CR10","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.ijrobp.2005.01.045","volume":"63","author":"AL Grosu","year":"2005","unstructured":"Grosu AL, Weber WA, Riedel E, Jeremic B, Nieder C, Franz M, Gumprecht H, Jaeger R, Schwaiger M, Molls M (2005) L-(methyl-11C) methionine positron emission tomography for target delineation in resected high-grade gliomas before radiotherapy. Int J Radiat Oncol Biol Phys 63:64\u201374","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"14_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2023.109663","volume":"184","author":"M Niyazi","year":"2023","unstructured":"Niyazi M, Andratschke N, Bendszus M, Chalmers AJ, Erridge SC, Galldiks N, Lagerwaard FJ, Navarria P, Munck Af Rosenschold P, Ricardi U, van den Bent MJ, Weller M, Belka C, Minniti G (2023) ESTRO-EANO guideline on target delineation and radiotherapy details for glioblastoma. Radiother Oncol 184:109663","journal-title":"Radiother Oncol"},{"key":"14_CR12","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1093\/neuonc\/now058","volume":"18","author":"NL Albert","year":"2016","unstructured":"Albert NL, Weller M, Suchorska B, Galldiks N, Soffietti R, Kim MM, la Fougere C, Pope W, Law I, Arbizu J, Chamberlain MC, Vogelbaum M, Ellingson BM, Tonn JC (2016) Response Assessment in Neuro-Oncology working group and European Association for Neuro-Oncology recommendations for the clinical use of PET imaging in gliomas. Neuro-Oncology 18:1199\u20131208","journal-title":"Neuro-Oncology"},{"key":"14_CR13","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1007\/s00259-018-4207-9","volume":"46","author":"I Law","year":"2019","unstructured":"Law I, Albert NL, Arbizu J, Boellaard R, Drzezga A, Galldiks N, la Fougere C, Langen KJ, Lopci E, Lowe V, McConathy J, Quick HH, Sattler B, Schuster DM, Tonn JC, Weller M (2019) Joint EANM\/EANO\/RANO practice guidelines\/SNMMI procedure standards for imaging of gliomas using PET with radiolabelled amino acids and [(18)F]FDG: version 1.0. Eur J Nucl Med Mol Imaging 46:540\u2013557","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"14_CR14","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1093\/neuonc\/noab013","volume":"23","author":"N Galldiks","year":"2021","unstructured":"Galldiks N, Niyazi M, Grosu AL, Kocher M, Langen KJ, Law I, Minniti G, Kim MM, Tsien C, Dhermain F, Soffietti R, Mehta MP, Weller M, Tonn JC (2021) Contribution of PET imaging to radiotherapy planning and monitoring in glioma patients - a report of the PET\/RANO group. Neuro-Oncology 23:881\u2013893","journal-title":"Neuro-Oncology"},{"key":"14_CR15","doi-asserted-by":"publisher","first-page":"184","DOI":"10.18383\/j.tom.2018.00028","volume":"5","author":"S Gurbani","year":"2019","unstructured":"Gurbani S, Weinberg B, Cooper L, Mellon E, Schreibmann E, Sheriff S, Maudsley A, Goryawala M, Shu HK, Shim H (2019) The Brain Imaging Collaboration Suite (BrICS): a cloud platform for integrating whole-brain spectroscopic MRI into the radiation therapy planning workflow. Tomography 5:184\u2013191","journal-title":"Tomography"},{"key":"14_CR16","doi-asserted-by":"publisher","first-page":"693","DOI":"10.2967\/jnumed.122.264859","volume":"64","author":"N Galldiks","year":"2023","unstructured":"Galldiks N, Lohmann P, Fink GR, Langen KJ (2023) Amino acid PET in neurooncology. J Nucl Med 64:693\u2013700","journal-title":"J Nucl Med"},{"key":"14_CR17","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/j.ijrobp.2005.01.056","volume":"63","author":"AL Grosu","year":"2005","unstructured":"Grosu AL, Weber WA, Franz M, Stark S, Piert M, Thamm R, Gumprecht H, Schwaiger M, Molls M, Nieder C (2005) Reirradiation of recurrent high-grade gliomas using amino acid PET (SPECT)\/CT\/MRI image fusion to determine gross tumor volume for stereotactic fractionated radiotherapy. Int J Radiat Oncol Biol Phys 63:511\u2013519","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"14_CR18","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1186\/s12885-016-2806-z","volume":"16","author":"O Oehlke","year":"2016","unstructured":"Oehlke O, Mix M, Graf E, Schimek-Jasch T, Nestle U, Gotz I, Schneider-Fuchs S, Weyerbrock A, Mader I, Baumert BG, Short SC, Meyer PT, Weber WA, Grosu AL (2016) Amino-acid PET versus MRI guided re-irradiation in patients with recurrent glioblastoma multiforme (GLIAA) - protocol of a randomized phase II trial (NOA 10\/ARO 2013-1). BMC Cancer 16:769","journal-title":"BMC Cancer"},{"key":"14_CR19","doi-asserted-by":"publisher","unstructured":"Grosu AL, Weber WA, Graf E, Mix M, Nestle U, Schimek-Jasch T, Wiehle R, Mader I, W\u00fcrtemberger U, Langen KJ, Niyazi M, Paulsen F, K\u00f6nig L, Giordano FA, Spehl I, Bernhardt D, Schymalla MM, P\u00f6ttgen C, Semrau S, Brunner T, H\u00fcltenschmidt B, Krause BJ, Ciernik IF, Beck J, Baumert BG, Meyer PT, Urbach H, Popp I, GLIAA Study Group (2026) O-(2-[18F]fluoroethyl)-L-tyrosine-PET-guided versus contrast-enhanced T1-weighted MRI-guided re-irradiation in patients with recurrent glioblastoma (GLIAA\/NOA-10ARO2013-01): a multicentre, open-label, randomised trial. Lancet Oncol. 27(2):169\u201380. https:\/\/doi.org\/10.1016\/S1470-2045(25)00642-4","DOI":"10.1016\/S1470-2045(25)00642-4"},{"key":"14_CR22","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1093\/neuonc\/nou131","volume":"17","author":"A Afshar-Oromieh","year":"2015","unstructured":"Afshar-Oromieh A, Wolf MB, Kratochwil C, Giesel FL, Combs SE, Dimitrakopoulou-Strauss A, Gnirs R, Roethke MC, Schlemmer HP, Haberkorn U (2015) Comparison of (6)(8)Ga-DOTATOC-PET\/CT and PET\/MRI hybrid systems in patients with cranial meningioma: initial results. Neuro-Oncology 17:312\u2013319","journal-title":"Neuro-Oncology"},{"key":"14_CR23","doi-asserted-by":"publisher","first-page":"347","DOI":"10.2967\/jnumed.114.149120","volume":"56","author":"W Rachinger","year":"2015","unstructured":"Rachinger W, Stoecklein VM, Terpolilli NA, Haug AR, Ertl L, Poschl J, Schuller U, Schichor C, Thon N, Tonn JC (2015) Increased 68Ga-DOTATATE uptake in PET imaging discriminates meningioma and tumor-free tissue. J Nucl Med 56:347\u2013353","journal-title":"J Nucl Med"},{"key":"14_CR24","doi-asserted-by":"publisher","first-page":"3662","DOI":"10.1007\/s00259-024-06783-x","volume":"51","author":"NL Albert","year":"2024","unstructured":"Albert NL, Preusser M, Traub-Weidinger T, Tolboom N, Law I, Palmer JD, Guedj E, Furtner J, Fraioli F, Huang RY, Johnson DR, Deroose CM, Herrmann K, Vogelbaum M, Chang S, Tonn JC, Weller M, Wen PY, van den Bent MJ, Verger A, Ivanidze J, Galldiks N (2024) Joint EANM\/EANO\/RANO\/SNMMI practice guideline\/procedure standards for diagnostics and therapy (theranostics) of meningiomas using radiolabeled somatostatin receptor ligands: version 1.0. Eur J Nucl Med Mol Imaging 51:3662\u20133679","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"14_CR25","doi-asserted-by":"publisher","first-page":"e383","DOI":"10.1016\/S1470-2045(16)30321-7","volume":"17","author":"R Goldbrunner","year":"2016","unstructured":"Goldbrunner R, Minniti G, Preusser M, Jenkinson MD, Sallabanda K, Houdart E, von Deimling A, Stavrinou P, Lefranc F, Lund-Johansen M, Moyal EC, Brandsma D, Henriksson R, Soffietti R, Weller M (2016) EANO guidelines for the diagnosis and treatment of meningiomas. Lancet Oncol 17:e383\u2013e391","journal-title":"Lancet Oncol"},{"key":"14_CR26","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.radonc.2018.03.006","volume":"127","author":"SE Combs","year":"2018","unstructured":"Combs SE, Farzin M, Boehmer J, Oehlke O, Molls M, Debus J, Grosu AL (2018) Clinical outcome after high-precision radiotherapy for skull base meningiomas: pooled data from three large German centers for radiation oncology. Radiother Oncol 127:274\u2013279","journal-title":"Radiother Oncol"},{"key":"14_CR27","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1016\/j.ijrobp.2008.02.058","volume":"72","author":"ST Astner","year":"2008","unstructured":"Astner ST, Dobrei-Ciuchendea M, Essler M, Bundschuh RA, Sai H, Schwaiger M, Molls M, Weber WA, Grosu AL (2008) Effect of 11C-methionine-positron emission tomography on gross tumor volume delineation in stereotactic radiotherapy of skull base meningiomas. Int J Radiat Oncol Biol Phys 72:1161\u20131167","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"14_CR28","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.ijrobp.2006.02.047","volume":"66","author":"AL Grosu","year":"2006","unstructured":"Grosu AL, Weber WA, Astner ST, Adam M, Krause BJ, Schwaiger M, Molls M, Nieder C (2006) 11C-methionine PET improves the target volume delineation of meningiomas treated with stereotactic fractionated radiotherapy. Int J Radiat Oncol Biol Phys 66:339\u2013344","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"14_CR29","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.ijrobp.2005.12.006","volume":"65","author":"S Milker-Zabel","year":"2006","unstructured":"Milker-Zabel S, Zabel-du Bois A, Henze M, Huber P, Schulz-Ertner D, Hoess A, Haberkorn U, Debus J (2006) Improved target volume definition for fractionated stereotactic radiotherapy in patients with intracranial meningiomas by correlation of CT, MRI, and [68Ga]-DOTATOC-PET. Int J Radiat Oncol Biol Phys 65:222\u2013227","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"14_CR30","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.ijrobp.2024.12.003","volume":"122","author":"HK Perlow","year":"2025","unstructured":"Perlow HK, Raleigh DR, Wang TJC, Pollom EL, Milano MT, Breen WG, Detsky J, Chang EL, Tom MC, Shiue KR, Lehrer EJ, Saeed H, Pike LRG, Lo SS, Mishra MV, Knisely JPS, Chao ST, Sahgal A, Palmer JD (2025) Consensus radiation treatment planning guidelines using (68)Ga-DOTATATE PET\/CT for resected Meningiomas. Int J Radiat Oncol Biol Phys 122:150\u2013158","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"14_CR31","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1093\/neuonc\/noae067","volume":"26","author":"J Ivanidze","year":"2024","unstructured":"Ivanidze J, Chang SJ, Haghdel A, Kim JT, Roy Choudhury A, Wu A, Ramakrishna R, Schwartz TH, Cisse B, Stieg P, Muller L, Osborne JR, Magge RS, Karakatsanis NA, Roytman M, Lin E, Pannullo SC, Palmer JD, Knisely JPS (2024) [Ga68] DOTATATE PET\/MRI-guided radiosurgical treatment planning and response assessment in meningiomas. Neuro-Oncology 26:1526\u20131535","journal-title":"Neuro-Oncology"},{"key":"14_CR32","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.radonc.2013.11.010","volume":"110","author":"GN Marta","year":"2014","unstructured":"Marta GN, Silva V, de Andrade CH, de Arruda FF, Hanna SA, Gadia R, da Silva JL, Correa SF, Vita Abreu CE, Riera R (2014) Intensity-modulated radiation therapy for head and neck cancer: systematic review and meta-analysis. Radiother Oncol 110:9\u201315","journal-title":"Radiother Oncol"},{"key":"14_CR33","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1148\/radiol.11101821","volume":"263","author":"HC Thoeny","year":"2012","unstructured":"Thoeny HC, De Keyzer F, King AD (2012) Diffusion-weighted MR imaging in the head and neck. Radiology 263:19\u201332","journal-title":"Radiology"},{"key":"14_CR34","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.2967\/jnumed.109.062638","volume":"50","author":"P Dirix","year":"2009","unstructured":"Dirix P, Vandecaveye V, De Keyzer F, Stroobants S, Hermans R, Nuyts S (2009) Dose painting in radiotherapy for head and neck squamous cell carcinoma: value of repeated functional imaging with (18)F-FDG PET, (18)F-fluoromisonidazole PET, diffusion-weighted MRI, and dynamic contrast-enhanced MRI. J Nucl Med 50:1020\u20131027","journal-title":"J Nucl Med"},{"key":"14_CR35","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1007\/s00330-010-1734-6","volume":"20","author":"V Vandecaveye","year":"2010","unstructured":"Vandecaveye V, Dirix P, De Keyzer F, de Beeck KO, Vander Poorten V, Roebben I, Nuyts S, Hermans R (2010) Predictive value of diffusion-weighted magnetic resonance imaging during chemoradiotherapy for head and neck squamous cell carcinoma. Eur Radiol 20:1703\u20131714","journal-title":"Eur Radiol"},{"key":"14_CR36","doi-asserted-by":"publisher","first-page":"2213","DOI":"10.1007\/s00330-010-1769-8","volume":"20","author":"AD King","year":"2010","unstructured":"King AD, Mo FK, Yu KH, Yeung DK, Zhou H, Bhatia KS, Tse GM, Vlantis AC, Wong JK, Ahuja AT (2010) Squamous cell carcinoma of the head and neck: diffusion-weighted MR imaging for prediction and monitoring of treatment response. Eur Radiol 20:2213\u20132220","journal-title":"Eur Radiol"},{"key":"14_CR37","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1148\/radiol.2331030660","volume":"233","author":"JF Daisne","year":"2004","unstructured":"Daisne JF, Duprez T, Weynand B, Lonneux M, Hamoir M, Reychler H, Gregoire V (2004) Tumor volume in pharyngolaryngeal squamous cell carcinoma: comparison at CT, MR imaging, and FDG PET and validation with surgical specimen. Radiology 233:93\u2013100","journal-title":"Radiology"},{"key":"14_CR38","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1053\/j.semnuclmed.2020.07.010","volume":"51","author":"K Jensen","year":"2021","unstructured":"Jensen K, Al-Farra G, Dejanovic D, Eriksen JG, Loft A, Hansen CR, Pameijer FA, Zukauskaite R, Grau C (2021) Imaging for target delineation in head and neck cancer radiotherapy. Semin Nucl Med 51:59\u201367","journal-title":"Semin Nucl Med"},{"key":"14_CR39","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s13014-023-02388-0","volume":"19","author":"Y Wang","year":"2024","unstructured":"Wang Y, Lombardo E, Huang L, Avanzo M, Fanetti G, Franchin G, Zschaeck S, Weingartner J, Belka C, Riboldi M, Kurz C, Landry G (2024) Comparison of deep learning networks for fully automated head and neck tumor delineation on multi-centric PET\/CT images. Radiat Oncol 19:3","journal-title":"Radiat Oncol"},{"key":"14_CR40","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.radonc.2014.06.001","volume":"111","author":"AK Due","year":"2014","unstructured":"Due AK, Vogelius IR, Aznar MC, Bentzen SM, Berthelsen AK, Korreman SS, Loft A, Kristensen CA, Specht L (2014) Recurrences after intensity modulated radiotherapy for head and neck squamous cell carcinoma more likely to originate from regions with high baseline [18F]-FDG uptake. Radiother Oncol 111:360\u2013365","journal-title":"Radiother Oncol"},{"key":"14_CR41","doi-asserted-by":"publisher","first-page":"217","DOI":"10.3109\/0284186X.2015.1046997","volume":"55","author":"S Differding","year":"2016","unstructured":"Differding S, Sterpin E, Janssens G, Hanin FX, Lee JA, Gregoire V (2016) Methodology for adaptive and robust FDG-PET escalated dose painting by numbers in head and neck tumors. Acta Oncol 55:217\u2013225","journal-title":"Acta Oncol"},{"key":"14_CR42","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.semradonc.2006.04.006","volume":"16","author":"V Gregoire","year":"2006","unstructured":"Gregoire V, Bol A, Geets X, Lee J (2006) Is PET-based treatment planning the new standard in modern radiotherapy? The head and neck paradigm. Semin Radiat Oncol 16:232\u2013238","journal-title":"Semin Radiat Oncol"},{"key":"14_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2024.110281","volume":"196","author":"A de Leeuw","year":"2024","unstructured":"de Leeuw A, Giralt J, Tao Y, Benavente S, France Nguyen TV, Hoebers FJP, Hoeben A, Terhaard CHJ, Wai Lee L, Friesland S, Steenbakkers R, Tans L, Heukelom J, Kayembe MT, van Kranen SR, Bartelink H, Rasch CRN, Sonke JJ, Hamming-Vrieze O (2024) A multicentric randomized controlled phase III trial of adaptive and 18F-FDG-PET-guided dose-redistribution in locally advanced head and neck squamous cell carcinoma (ARTFORCE). Radiother Oncol 196:110281","journal-title":"Radiother Oncol"},{"key":"14_CR44","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1038\/bjc.2014.610","volume":"112","author":"IN Fleming","year":"2015","unstructured":"Fleming IN, Manavaki R, Blower PJ, West C, Williams KJ, Harris AL, Domarkas J, Lord S, Baldry C, Gilbert FJ (2015) Imaging tumour hypoxia with positron emission tomography. Br J Cancer 112:238\u2013250","journal-title":"Br J Cancer"},{"key":"14_CR45","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.radonc.2005.06.038","volume":"77","author":"M Nordsmark","year":"2005","unstructured":"Nordsmark M, Bentzen SM, Rudat V, Brizel D, Lartigau E, Stadler P, Becker A, Adam M, Molls M, Dunst J, Terris DJ, Overgaard J (2005) Prognostic value of tumor oxygenation in 397 head and neck tumors after primary radiation therapy. An international multi-center study. Radiother Oncol 77:18\u201324","journal-title":"Radiother Oncol"},{"key":"14_CR46","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1007\/s00066-004-1229-y","volume":"180","author":"B Gagel","year":"2004","unstructured":"Gagel B, Reinartz P, Dimartino E, Zimny M, Pinkawa M, Maneschi P, Stanzel S, Hamacher K, Coenen HH, Westhofen M, Bull U, Eble MJ (2004) pO(2) Polarography versus positron emission tomography ([(18)F] fluoromisonidazole, [(18)F]-2-fluoro-2\u2032-deoxyglucose). An appraisal of radiotherapeutically relevant hypoxia. Strahlenther Onkol 180:616\u2013622","journal-title":"Strahlenther Onkol"},{"key":"14_CR47","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.radonc.2015.09.015","volume":"117","author":"NE Wiedenmann","year":"2015","unstructured":"Wiedenmann NE, Bucher S, Hentschel M, Mix M, Vach W, Bittner MI, Nestle U, Pfeiffer J, Weber WA, Grosu AL (2015) Serial [18F]-fluoromisonidazole PET during radiochemotherapy for locally advanced head and neck cancer and its correlation with outcome. Radiother Oncol 117:113\u2013117","journal-title":"Radiother Oncol"},{"key":"14_CR48","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.radonc.2012.08.019","volume":"105","author":"D Zips","year":"2012","unstructured":"Zips D, Zophel K, Abolmaali N, Perrin R, Abramyuk A, Haase R, Appold S, Steinbach J, Kotzerke J, Baumann M (2012) Exploratory prospective trial of hypoxia-specific PET imaging during radiochemotherapy in patients with locally advanced head-and-neck cancer. Radiother Oncol 105:21\u201328","journal-title":"Radiother Oncol"},{"key":"14_CR49","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/j.radonc.2013.06.012","volume":"108","author":"MI Bittner","year":"2013","unstructured":"Bittner MI, Wiedenmann N, Bucher S, Hentschel M, Mix M, Weber WA, Grosu AL (2013) Exploratory geographical analysis of hypoxic subvolumes using 18F-MISO-PET imaging in patients with head and neck cancer in the course of primary chemoradiotherapy. Radiother Oncol 108:511\u2013516","journal-title":"Radiother Oncol"},{"key":"14_CR50","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.ijrobp.2016.04.027","volume":"96","author":"N Lee","year":"2016","unstructured":"Lee N, Schoder H, Beattie B, Lanning R, Riaz N, McBride S, Katabi N, Li D, Yarusi B, Chan S, Mitrani L, Zhang Z, Pfister DG, Sherman E, Baxi S, Boyle J, Morris LG, Ganly I, Wong R, Humm J (2016) Strategy of using intratreatment hypoxia imaging to selectively and safely guide radiation dose de-escalation concurrent with chemotherapy for locoregionally advanced human papillomavirus-related oropharyngeal carcinoma. Int J Radiat Oncol Biol Phys 96:9\u201317","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"14_CR51","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/j.ijrobp.2007.05.079","volume":"69","author":"AL Grosu","year":"2007","unstructured":"Grosu AL, Souvatzoglou M, Roper B, Dobritz M, Wiedenmann N, Jacob V, Wester HJ, Reischl G, Machulla HJ, Schwaiger M, Molls M, Piert M (2007) Hypoxia imaging with FAZA-PET and theoretical considerations with regard to dose painting for individualization of radiotherapy in patients with head and neck cancer. Int J Radiat Oncol Biol Phys 69:541\u2013551","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"14_CR52","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1056\/NEJMoa1514493","volume":"374","author":"H Mehanna","year":"2016","unstructured":"Mehanna H, Wong WL, McConkey CC, Rahman JK, Robinson M, Hartley AG, Nutting C, Powell N, Al-Booz H, Robinson M, Junor E, Rizwanullah M, von Zeidler SV, Wieshmann H, Hulme C, Smith AF, Hall P, Dunn J, Group P-NTM (2016) PET-CT surveillance versus neck dissection in advanced head and neck cancer. N Engl J Med 374:1444\u20131454","journal-title":"N Engl J Med"},{"key":"14_CR53","unstructured":"Pfister DG, Foote RL, Gilbert J, Gillison ML, Ridge JA, Rocco J (2018) NCCN guidelines index table of contents discussion 227"},{"key":"14_CR54","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/S0360-3016(99)00061-9","volume":"44","author":"U Nestle","year":"1999","unstructured":"Nestle U, Walter K, Schmidt S, Licht N, Nieder C, Motaref B, Hellwig D, Niewald M, Ukena D, Kirsch CM, Sybrecht GW, Schnabel K (1999) 18F-deoxyglucose positron emission tomography (FDG-PET) for the planning of radiotherapy in lung cancer: high impact in patients with atelectasis. Int J Radiat Oncol Biol Phys 44:593\u2013597","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"14_CR55","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1016\/j.ijrobp.2004.12.019","volume":"62","author":"D De Ruysscher","year":"2005","unstructured":"De Ruysscher D, Wanders S, van Haren E, Hochstenbag M, Geeraedts W, Utama I, Simons J, Dohmen J, Rhami A, Buell U, Thimister P, Snoep G, Boersma L, Verschueren T, van Baardwijk A, Minken A, Bentzen SM, Lambin P (2005) Selective mediastinal node irradiation based on FDG-PET scan data in patients with non-small-cell lung cancer: a prospective clinical study. Int J Radiat Oncol Biol Phys 62:988\u2013994","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"14_CR56","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1016\/S0360-3016(01)01722-9","volume":"51","author":"CB Caldwell","year":"2001","unstructured":"Caldwell CB, Mah K, Ung YC, Danjoux CE, Balogh JM, Ganguli SN, Ehrlich LE (2001) Observer variation in contouring gross tumor volume in patients with poorly defined non-small-cell lung tumors on CT: the impact of 18FDG-hybrid PET fusion. Int J Radiat Oncol Biol Phys 51:923\u2013931","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"14_CR57","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.ijrobp.2004.09.020","volume":"62","author":"JL Fox","year":"2005","unstructured":"Fox JL, Rengan R, O'Meara W, Yorke E, Erdi Y, Nehmeh S, Leibel SA, Rosenzweig KE (2005) Does registration of PET and planning CT images decrease interobserver and intraobserver variation in delineating tumor volumes for non-small-cell lung cancer? Int J Radiat Oncol Biol Phys 62:70\u201375","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"14_CR58","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.ijrobp.2009.04.045","volume":"77","author":"GG Hanna","year":"2010","unstructured":"Hanna GG, McAleese J, Carson KJ, Stewart DP, Cosgrove VP, Eakin RL, Zatari A, Lynch T, Jarritt PH, Young VA, O'Sullivan JM, Hounsell AR (2010) (18)F-FDG PET-CT simulation for non-small-cell lung cancer: effect in patients already staged by PET-CT. Int J Radiat Oncol Biol Phys 77:24\u201330","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"14_CR59","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1148\/radiology.213.2.r99nv46530","volume":"213","author":"BA Dwamena","year":"1999","unstructured":"Dwamena BA, Sonnad SS, Angobaldo JO, Wahl RL (1999) Metastases from non-small cell lung cancer: mediastinal staging in the 1990s\u2014meta-analytic comparison of PET and CT. Radiology 213:530\u2013536","journal-title":"Radiology"},{"key":"14_CR60","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.ijrobp.2008.01.019","volume":"71","author":"MP Macmanus","year":"2008","unstructured":"Macmanus MP, Hicks RJ (2008) Where do we draw the line? Contouring tumors on positron emission tomography\/computed tomography. Int J Radiat Oncol Biol Phys 71:2\u20134","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"14_CR61","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1007\/s00066-014-0644-y","volume":"190","author":"C Doll","year":"2014","unstructured":"Doll C, Duncker-Rohr V, Rucker G, Mix M, MacManus M, De Ruysscher D, Vogel W, Eriksen JG, Oyen W, Grosu AL, Weber W, Nestle U (2014) Influence of experience and qualification on PET-based target volume delineation. When there is no expert--ask your colleague. Strahlenther Onkol 190:555\u2013562","journal-title":"Strahlenther Onkol"},{"key":"14_CR62","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.radonc.2008.11.008","volume":"91","author":"M MacManus","year":"2009","unstructured":"MacManus M, Nestle U, Rosenzweig KE, Carrio I, Messa C, Belohlavek O, Danna M, Inoue T, Deniaud-Alexandre E, Schipani S, Watanabe N, Dondi M, Jeremic B (2009) Use of PET and PET\/CT for radiation therapy planning: IAEA expert report 2006-2007. Radiother Oncol 91:85\u201394","journal-title":"Radiother Oncol"},{"key":"14_CR63","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.radonc.2015.03.014","volume":"116","author":"T Konert","year":"2015","unstructured":"Konert T, Vogel W, MacManus MP, Nestle U, Belderbos J, Gregoire V, Thorwarth D, Fidarova E, Paez D, Chiti A, Hanna GG (2015) PET\/CT imaging for target volume delineation in curative intent radiotherapy of non-small cell lung cancer: IAEA consensus report 2014. Radiother Oncol 116:27\u201334","journal-title":"Radiother Oncol"},{"key":"14_CR64","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.radonc.2015.05.019","volume":"115","author":"A Chirindel","year":"2015","unstructured":"Chirindel A, Adebahr S, Schuster D, Schimek-Jasch T, Schanne DH, Nemer U, Mix M, Meyer P, Grosu AL, Brunner T, Nestle U (2015) Impact of 4D-(18)FDG-PET\/CT imaging on target volume delineation in SBRT patients with central versus peripheral lung tumors. Multi-reader comparative study. Radiother Oncol 115:335\u2013341","journal-title":"Radiother Oncol"},{"key":"14_CR65","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1016\/j.jtho.2024.05.366","volume":"19","author":"A Levy","year":"2024","unstructured":"Levy A, Adebahr S, Hurkmans C, Ahmed M, Ahmad S, Guckenberger M, Geets X, Lievens Y, Lambrecht M, Pourel N, Lewitzki V, Konopa K, Franks K, Dziadziuszko R, McDonald F, Fortpied C, Clementel E, Fournier B, Rizzo S, Fink C, Riesterer O, Peulen H, Andratschke N, McWilliam A, Gkika E, Schimek-Jasch T, Grosu AL, Le Pechoux C, Faivre-Finn C, Nestle U (2024) Stereotactic body radiotherapy for centrally located inoperable early-stage NSCLC: EORTC 22113-08113 LungTech phase II trial results. J Thorac Oncol 19:1297\u20131309","journal-title":"J Thorac Oncol"},{"key":"14_CR66","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/S1470-2045(20)30013-9","volume":"21","author":"U Nestle","year":"2020","unstructured":"Nestle U, Schimek-Jasch T, Kremp S, Schaefer-Schuler A, Mix M, Kusters A, Tosch M, Hehr T, Eschmann SM, Bultel YP, Hass P, Fleckenstein J, Thieme A, Stockinger M, Dieckmann K, Miederer M, Holl G, Rischke HC, Gkika E, Adebahr S, Konig J, Grosu AL, group PE-Ps (2020) Imaging-based target volume reduction in chemoradiotherapy for locally advanced non-small-cell lung cancer (PET-Plan): a multicentre, open-label, randomised, controlled trial. Lancet Oncol 21:581\u2013592","journal-title":"Lancet Oncol"},{"key":"14_CR67","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1016\/j.ijrobp.2025.02.041","volume":"122","author":"A Rimner","year":"2025","unstructured":"Rimner A, Dejonckheere CS, Sahlmann J, Barth SA, Schimek-Jasch T, Adebahr S, Hecht M, Waller CF, Schmid S, Stolz D, Miederer M, Brose A, Binder H, Konig J, Grosu AL, Nestle U, Gkika E (2025) Impact of different mediastinal staging modalities on target volume delineation in locally advanced non-small cell lung cancer: a secondary analysis of the multicenter randomized PET-plan trial. Int J Radiat Oncol Biol Phys 122:1217\u20131226","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"14_CR68","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1016\/S1470-2045(24)00320-6","volume":"25","author":"P Vera","year":"2024","unstructured":"Vera P, Thureau S, Le Tinier F, Chaumet-Riffaud P, Hapdey S, Kolesnikov-Gauthier H, Martin E, Berriolo-Riedinger A, Pourel N, Broglia JM, Boissellier P, Guillemard S, Salem N, Brenot-Rossi I, Le Pechoux C, Berthold C, Giroux-Leprieur E, Moreau D, Guillerm S, Benali K, Tessonnier L, Audigier-Valette C, Lerouge D, Quak E, Massabeau C, Courbon F, Moisson P, Larrouy A, Modzelewski R, Gouel P, Ghazzar N, Langlais A, Amour E, Zalcman G, Giraud P (2024) Adaptive radiotherapy (up to 74 Gy) or standard radiotherapy (66 Gy) for patients with stage III non-small-cell lung cancer, according to [(18)F]FDG-PET tumour residual uptake at 42 Gy (RTEP7-IFCT-1402): a multicentre, randomised, controlled phase 2 trial. Lancet Oncol 25:1176\u20131187","journal-title":"Lancet Oncol"},{"key":"14_CR69","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1053\/j.semnuclmed.2025.02.009","volume":"55","author":"F Alorfi","year":"2025","unstructured":"Alorfi F, Bomanji J, Bertoletti L, Fraioli F (2025) PET\/MRI in non-small cell lung cancer (NSCLC). Semin Nucl Med 55:234\u2013239","journal-title":"Semin Nucl Med"},{"key":"14_CR70","doi-asserted-by":"publisher","first-page":"v50","DOI":"10.1093\/annonc\/mdw329","volume":"27","author":"F Lordick","year":"2016","unstructured":"Lordick F, Mariette C, Haustermans K, Obermannova R, Arnold D, Committee EG (2016) Oesophageal cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 27:v50\u2013vv7","journal-title":"Ann Oncol"},{"key":"14_CR71","doi-asserted-by":"publisher","first-page":"830","DOI":"10.6004\/jnccn.2011.0072","volume":"9","author":"JA Ajani","year":"2011","unstructured":"Ajani JA, Barthel JS, Bentrem DJ, D'Amico TA, Das P, Denlinger CS, Fuchs CS, Gerdes H, Glasgow RE, Hayman JA, Hofstetter WL, Ilson DH, Keswani RN, Kleinberg LR, Korn WM, Lockhart AC, Mulcahy MF, Orringer MB, Osarogiagbon RU, Posey JA, Sasson AR, Scott WJ, Shibata S, Strong VE, Varghese TK Jr, Warren G, Washington MK, Willett C, Wright CD, National Comprehensive Cancer N (2011) Esophageal and esophagogastric junction cancers. J Natl Compr Cancer Netw 9:830\u2013887","journal-title":"J Natl Compr Cancer Netw"},{"key":"14_CR72","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.radonc.2010.04.024","volume":"97","author":"CT Muijs","year":"2010","unstructured":"Muijs CT, Beukema JC, Pruim J, Mul VE, Groen H, Plukker JT, Langendijk JA (2010) A systematic review on the role of FDG-PET\/CT in tumour delineation and radiotherapy planning in patients with esophageal cancer. Radiother Oncol 97:165\u2013171","journal-title":"Radiother Oncol"},{"key":"14_CR73","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1038\/sj.bjc.6604200","volume":"98","author":"EP van Vliet","year":"2008","unstructured":"van Vliet EP, Heijenbrok-Kal MH, Hunink MG, Kuipers EJ, Siersema PD (2008) Staging investigations for oesophageal cancer: a meta-analysis. Br J Cancer 98:547\u2013557","journal-title":"Br J Cancer"},{"key":"14_CR74","doi-asserted-by":"publisher","first-page":"3805","DOI":"10.1200\/JCO.2004.01.083","volume":"22","author":"HL van Westreenen","year":"2004","unstructured":"van Westreenen HL, Westerterp M, Bossuyt PM, Pruim J, Sloof GW, van Lanschot JJ, Groen H, Plukker JT (2004) Systematic review of the staging performance of 18F-fluorodeoxyglucose positron emission tomography in esophageal cancer. J Clin Oncol 22:3805\u20133812","journal-title":"J Clin Oncol"},{"key":"14_CR75","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.radonc.2014.10.016","volume":"113","author":"CT Muijs","year":"2014","unstructured":"Muijs CT, Beukema JC, Woutersen D, Mul VE, Berveling MJ, Pruim J, van der Jagt EJ, Hospers GA, Groen H, Plukker JT, Langendijk JA (2014) Clinical validation of FDG-PET\/CT in the radiation treatment planning for patients with oesophageal cancer. Radiother Oncol 113:188\u2013192","journal-title":"Radiother Oncol"},{"key":"14_CR76","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.2967\/jnumed.110.085803","volume":"52","author":"K Herrmann","year":"2011","unstructured":"zum Buschenfelde CM, Herrmann K, Schuster T, Geinitz H, Langer R, Becker K, Ott K, Ebert M, Zimmermann F, Friess H, Schwaiger M, Peschel C, Lordick F, Krause BJ (2011) (18)F-FDG PET-guided salvage neoadjuvant radiochemotherapy of adenocarcinoma of the esophagogastric junction: the MUNICON II trial. J Nucl Med 52:1189\u20131196","journal-title":"J Nucl Med"},{"key":"14_CR77","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1177\/1533034615627583","volume":"16","author":"J Ma","year":"2017","unstructured":"Ma J, Wang Z, Wang C, Chen E, Dong Y, Song Y, Wang W, You D, Jiang W, Zang R (2017) Individualized radiation dose escalation based on the decrease in tumor FDG uptake and normal tissue constraints improve survival in patients with esophageal carcinoma. Technol Cancer Res Treat 16:75\u201380","journal-title":"Technol Cancer Res Treat"},{"key":"14_CR78","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.875081","volume":"12","author":"H Liu","year":"2022","unstructured":"Liu H, Hu Z, Yang X, Dai T, Chen Y (2022) Comparison of [(68)Ga]Ga-DOTA-FAPI-04 and [(18)F]FDG uptake in esophageal cancer. Front Oncol 12:875081","journal-title":"Front Oncol"},{"key":"14_CR79","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s13014-025-02606-x","volume":"20","author":"K Kroger","year":"2025","unstructured":"Kroger K, Pepper NB, Ventura D, Troschel FM, Backhaus P, Rahbar K, Glasbrenner B, Bruwer M, Pascher A, Schafers M, Eich HT, Roll W (2025) FAPI-PET\/CT guided radiotherapy for patients with esophageal cancer. Radiat Oncol 20:29","journal-title":"Radiat Oncol"},{"key":"14_CR80","doi-asserted-by":"publisher","first-page":"625","DOI":"10.2967\/jnumed.122.264638","volume":"64","author":"X Hu","year":"2023","unstructured":"Hu X, Zhou T, Ren J, Duan J, Wu H, Liu X, Mu Z, Liu N, Wei Y, Yuan S (2023) Response prediction using (18)F-FAPI-04 PET\/CT in patients with esophageal squamous cell carcinoma treated with concurrent chemoradiotherapy. J Nucl Med 64:625\u2013631","journal-title":"J Nucl Med"},{"key":"14_CR81","unstructured":"Mohler JL, Lee RJ, Antonarakis ES, Higano CS, Richey S (2018) NCCN guidelines index table of contents. Prostate Cancer 151"},{"key":"14_CR82","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1200\/JOP.18.00434","volume":"14","author":"JE Bekelman","year":"2018","unstructured":"Bekelman JE, Rumble RB, Freedland SJ (2018) Clinically localized prostate cancer: ASCO clinical practice guideline endorsement of an AUA\/ASTRO\/SUO guideline summary. J Oncol Pract 14:618\u2013624","journal-title":"J Oncol Pract"},{"key":"14_CR83","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/j.eururo.2016.08.003","volume":"71","author":"N Mottet","year":"2017","unstructured":"Mottet N, Bellmunt J, Bolla M, Briers E, Cumberbatch MG, De Santis M, Fossati N, Gross T, Henry AM, Joniau S, Lam TB, Mason MD, Matveev VB, Moldovan PC, van den Bergh RCN, Van den Broeck T, van der Poel HG, van der Kwast TH, Rouviere O, Schoots IG, Wiegel T, Cornford P (2017) EAU-ESTRO-SIOG guidelines on prostate cancer. Part 1: screening, diagnosis, and local treatment with curative intent. Eur Urol 71:618\u2013629","journal-title":"Eur Urol"},{"key":"14_CR84","unstructured":"NCCN Clinical Practice Guidelines in Oncology: Prostate Cancer, Version 2.2025"},{"issue":"4","key":"14_CR85","first-page":"1","volume":"80","author":"P Cornford","year":"2024","unstructured":"Cornford P, van den Bergh RCN, Briers E et al (2024) EAU-EANM-ESTRO-ESUR-ISUP-SIOG guidelines on prostate cancer (2024 update). Eur Urol 80(4):1\u201350","journal-title":"Eur Urol"},{"key":"14_CR86","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/S1470-2045(07)70143-2","volume":"8","author":"DP Dearnaley","year":"2007","unstructured":"Dearnaley DP, Sydes MR, Graham JD, Aird EG, Bottomley D, Cowan RA, Huddart RA, Jose CC, Matthews JH, Millar J, Moore AR, Morgan RC, Russell JM, Scrase CD, Stephens RJ, Syndikus I, Parmar MK, collaborators RT (2007) Escalated-dose versus standard-dose conformal radiotherapy in prostate cancer: first results from the MRC RT01 randomised controlled trial. Lancet Oncol 8:475\u2013487","journal-title":"Lancet Oncol"},{"key":"14_CR87","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1016\/j.ijrobp.2010.01.006","volume":"79","author":"DA Kuban","year":"2011","unstructured":"Kuban DA, Levy LB, Cheung MR, Lee AK, Choi S, Frank S, Pollack A (2011) Long-term failure patterns and survival in a randomized dose-escalation trial for prostate cancer. Who dies of disease? Int J Radiat Oncol Biol Phys 79:1310\u20131317","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"14_CR88","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.ijrobp.2007.06.054","volume":"70","author":"DA Kuban","year":"2008","unstructured":"Kuban DA, Tucker SL, Dong L, Starkschall G, Huang EH, Cheung MR, Lee AK, Pollack A (2008) Long-term results of the M. D. Anderson randomized dose-escalation trial for prostate cancer. Int J Radiat Oncol Biol Phys 70:67\u201374","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"14_CR89","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1016\/j.ijrobp.2008.10.091","volume":"74","author":"GA Viani","year":"2009","unstructured":"Viani GA, Stefano EJ, Afonso SL (2009) Higher-than-conventional radiation doses in localized prostate cancer treatment: a meta-analysis of randomized, controlled trials. Int J Radiat Oncol Biol Phys 74:1405\u20131418","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"14_CR90","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1001\/jama.294.10.1233","volume":"294","author":"AL Zietman","year":"2005","unstructured":"Zietman AL, DeSilvio ML, Slater JD, Rossi CJ Jr, Miller DW, Adams JA, Shipley WU (2005) Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: a randomized controlled trial. JAMA 294:1233\u20131239","journal-title":"JAMA"},{"key":"14_CR91","doi-asserted-by":"publisher","first-page":"343","DOI":"10.2214\/AJR.13.11046","volume":"202","author":"M de Rooij","year":"2014","unstructured":"de Rooij M, Hamoen EH, Futterer JJ, Barentsz JO, Rovers MM (2014) Accuracy of multiparametric MRI for prostate cancer detection: a meta-analysis. AJR Am J Roentgenol 202:343\u2013351","journal-title":"AJR Am J Roentgenol"},{"key":"14_CR92","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.eururo.2017.01.042","volume":"72","author":"S Woo","year":"2017","unstructured":"Woo S, Suh CH, Kim SY, Cho JY, Kim SH (2017) Diagnostic performance of prostate imaging reporting and data system Version 2 for detection of prostate cancer: a systematic review and diagnostic meta-analysis. Eur Urol 72:177\u2013188","journal-title":"Eur Urol"},{"key":"14_CR93","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.radonc.2018.04.015","volume":"128","author":"MA van Schie","year":"2018","unstructured":"van Schie MA, Dinh CV, Houdt PJV, Pos FJ, Heijmink S, Kerkmeijer LGW, Kotte A, Oyen R, Haustermans K, van der Heide UA (2018) Contouring of prostate tumors on multiparametric MRI: evaluation of clinical delineations in a multicenter radiotherapy trial. Radiother Oncol 128:321\u2013326","journal-title":"Radiother Oncol"},{"key":"14_CR94","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.radonc.2015.04.012","volume":"115","author":"P Steenbergen","year":"2015","unstructured":"Steenbergen P, Haustermans K, Lerut E, Oyen R, De Wever L, Van den Bergh L, Kerkmeijer LG, Pameijer FA, Veldhuis WB, van der Voort van Zyp JR, Pos FJ, Heijmink SW, Kalisvaart R, Teertstra HJ, Dinh CV, Ghobadi G, van der Heide UA (2015) Prostate tumor delineation using multiparametric magnetic resonance imaging: inter-observer variability and pathology validation. Radiother Oncol 115:186\u2013190","journal-title":"Radiother Oncol"},{"key":"14_CR95","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1002\/mrm.23062","volume":"67","author":"T Barrett","year":"2012","unstructured":"Barrett T, Gill AB, Kataoka MY, Priest AN, Joubert I, McLean MA, Graves MJ, Stearn S, Lomas DJ, Griffiths JR, Neal D, Gnanapragasam VJ, Sala E (2012) DCE and DW MRI in monitoring response to androgen deprivation therapy in patients with prostate cancer: a feasibility study. Magn Reson Med 67:778\u2013785","journal-title":"Magn Reson Med"},{"key":"14_CR96","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1080\/09553000903090027","volume":"85","author":"M Schmuecking","year":"2009","unstructured":"Schmuecking M, Boltze C, Geyer H, Salz H, Schilling B, Wendt TG, Kloetzer KH, Marx C (2009) Dynamic MRI and CAD vs. choline MRS: where is the detection level for a lesion characterisation in prostate cancer? Int J Radiat Biol 85:814\u2013824","journal-title":"Int J Radiat Biol"},{"key":"14_CR97","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1148\/rg.313105139","volume":"31","author":"D Bonekamp","year":"2011","unstructured":"Bonekamp D, Jacobs MA, El-Khouli R, Stoianovici D, Macura KJ (2011) Advancements in MR imaging of the prostate: from diagnosis to interventions. Radiographics 31:677\u2013703","journal-title":"Radiographics"},{"key":"14_CR98","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.eururo.2015.08.052","volume":"69","author":"JC Weinreb","year":"2016","unstructured":"Weinreb JC, Barentsz JO, Choyke PL, Cornud F, Haider MA, Macura KJ, Margolis D, Schnall MD, Shtern F, Tempany CM, Thoeny HC, Verma S (2016) PI-RADS prostate imaging - reporting and data system: 2015, Version 2. Eur Urol 69:16\u201340","journal-title":"Eur Urol"},{"key":"14_CR99","unstructured":"PI-RADS Prostate Imaging - Reporting and Data System: 2019, Version 2.1"},{"key":"14_CR100","doi-asserted-by":"publisher","first-page":"81","DOI":"10.2967\/jnumed.110.077941","volume":"52","author":"H Jadvar","year":"2011","unstructured":"Jadvar H (2011) Prostate cancer: PET with 18F-FDG, 18F- or 11C-acetate, and 18F- or 11C-choline. J Nucl Med 52:81\u201389","journal-title":"J Nucl Med"},{"key":"14_CR101","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1007\/s00259-013-2345-7","volume":"40","author":"RA Bundschuh","year":"2013","unstructured":"Bundschuh RA, Wendl CM, Weirich G, Eiber M, Souvatzoglou M, Treiber U, Kubler H, Maurer T, Gschwend JE, Geinitz H, Grosu AL, Ziegler SI, Krause BJ (2013) Tumour volume delineation in prostate cancer assessed by [11C]choline PET\/CT: validation with surgical specimens. Eur J Nucl Med Mol Imaging 40:824\u2013831","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"14_CR102","doi-asserted-by":"publisher","first-page":"2242","DOI":"10.1007\/s00259-014-2861-0","volume":"41","author":"AL Grosu","year":"2014","unstructured":"Grosu AL, Weirich G, Wendl C, Prokic V, Kirste S, Geinitz H, Souvatzoglou M, Gschwend JE, Schwaiger M, Molls M, Weber WA, Treiber U, Krause BJ (2014) 11C-Choline PET\/pathology image coregistration in primary localized prostate cancer. Eur J Nucl Med Mol Imaging 41:2242\u20132248","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"14_CR103","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1007\/s00259-016-3346-0","volume":"43","author":"FL Giesel","year":"2016","unstructured":"Giesel FL, Sterzing F, Schlemmer HP, Holland-Letz T, Mier W, Rius M, Afshar-Oromieh A, Kopka K, Debus J, Haberkorn U, Kratochwil C (2016) Intra-individual comparison of (68)Ga-PSMA-11-PET\/CT and multi-parametric MR for imaging of primary prostate cancer. Eur J Nucl Med Mol Imaging 43:1400\u20131406","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"14_CR104","doi-asserted-by":"publisher","first-page":"2796","DOI":"10.1007\/s00259-020-04827-6","volume":"47","author":"S Spohn","year":"2020","unstructured":"Spohn S, Jaegle C, Fassbender TF, Sprave T, Gkika E, Nicolay NH, Bock M, Ruf J, Benndorf M, Gratzke C, Grosu AL, Zamboglou C (2020) Intraindividual comparison between (68)Ga-PSMA-PET\/CT and mpMRI for intraprostatic tumor delineation in patients with primary prostate cancer: a retrospective analysis in 101 patients. Eur J Nucl Med Mol Imaging 47:2796\u20132803","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"14_CR105","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.880042","volume":"12","author":"IM Marinescu","year":"2022","unstructured":"Marinescu IM, Spohn SKB, Kiefer S, Bronsert P, Ceci L, Holzschuh J, Sigle A, Jilg CA, Ruhle A, Sprave T, Nicolay NH, Winzer R, Rehm J, Kotzerke J, Holscher T, Grosu AL, Ruf J, Benndorf M, Zamboglou C (2022) Intraindividual comparison between [(18)F] PSMA-1007 PET\/CT and multiparametric MRI for radiotherapy planning in primary prostate cancer patients. Front Oncol 12:880042","journal-title":"Front Oncol"},{"key":"14_CR106","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2023.109774","volume":"188","author":"JC Holzschuh","year":"2023","unstructured":"Holzschuh JC, Mix M, Ruf J, Holscher T, Kotzerke J, Vrachimis A, Doolan P, Ilhan H, Marinescu IM, Spohn SKB, Fechter T, Kuhn D, Bronsert P, Gratzke C, Grosu R, Kamran SC, Heidari P, Ng TSC, Konik A, Grosu AL, Zamboglou C (2023) Deep learning based automated delineation of the intraprostatic gross tumour volume in PSMA-PET for patients with primary prostate cancer. Radiother Oncol 188:109774","journal-title":"Radiother Oncol"},{"key":"14_CR107","doi-asserted-by":"publisher","first-page":"823","DOI":"10.2967\/jnumed.120.254623","volume":"62","author":"D Kostyszyn","year":"2021","unstructured":"Kostyszyn D, Fechter T, Bartl N, Grosu AL, Gratzke C, Sigle A, Mix M, Ruf J, Fassbender TF, Kiefer S, Bettermann AS, Nicolay NH, Spohn S, Kramer MU, Bronsert P, Guo H, Qiu X, Wang F, Henkenberens C, Werner RA, Baltas D, Meyer PT, Derlin T, Chen M, Zamboglou C (2021) Intraprostatic tumor segmentation on PSMA PET images in patients with primary prostate cancer with a convolutional neural network. J Nucl Med 62:823\u2013828","journal-title":"J Nucl Med"},{"key":"14_CR108","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1007\/s00259-025-07078-5","volume":"52","author":"PMA Waibel","year":"2025","unstructured":"Waibel PMA, Glavynskyi I, Fechter T, Mix M, Kind F, Sigle A, Jilg CA, Gratzke C, Werner M, Schilling O, Bronsert P, Freitag MT, Zamboglou C, Grosu AL, Spohn SKB (2025) Can PSMA PET detect intratumour heterogeneity in histological PSMA expression of primary prostate cancer? Analysis of [(68)Ga]Ga-PSMA-11 and [(18)F]PSMA-1007. Eur J Nucl Med Mol Imaging 52:2023\u20132033","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"14_CR109","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1053\/j.semnuclmed.2025.03.006","volume":"55","author":"SKB Spohn","year":"2025","unstructured":"Spohn SKB, Grosu AL (2025) Impact of PSMA PET on radiation oncology planning. Semin Nucl Med 55:664","journal-title":"Semin Nucl Med"},{"key":"14_CR110","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/j.eururo.2015.12.053","volume":"70","author":"M Eiber","year":"2016","unstructured":"Eiber M, Weirich G, Holzapfel K, Souvatzoglou M, Haller B, Rauscher I, Beer AJ, Wester HJ, Gschwend J, Schwaiger M, Maurer T (2016) Simultaneous (68)Ga-PSMA HBED-CC PET\/MRI improves the localization of primary prostate cancer. Eur Urol 70:829\u2013836","journal-title":"Eur Urol"},{"key":"14_CR111","doi-asserted-by":"publisher","first-page":"228","DOI":"10.7150\/thno.16638","volume":"7","author":"C Zamboglou","year":"2017","unstructured":"Zamboglou C, Drendel V, Jilg CA, Rischke HC, Beck TI, Schultze-Seemann W, Krauss T, Mix M, Schiller F, Wetterauer U, Werner M, Langer M, Bock M, Meyer PT, Grosu AL (2017) Comparison of (68)Ga-HBED-CC PSMA-PET\/CT and multiparametric MRI for gross tumour volume detection in patients with primary prostate cancer based on slice by slice comparison with histopathology. Theranostics 7:228\u2013237","journal-title":"Theranostics"},{"key":"14_CR112","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1007\/s00259-018-3954-y","volume":"45","author":"L Thomas","year":"2018","unstructured":"Thomas L, Kantz S, Hung A, Monaco D, Gaertner FC, Essler M, Strunk H, Laub W, Bundschuh RA (2018) (68)Ga-PSMA-PET\/CT imaging of localized primary prostate cancer patients for intensity modulated radiation therapy treatment planning with integrated boost. Eur J Nucl Med Mol Imaging 45:1170\u20131178","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"14_CR113","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/j.radonc.2017.04.021","volume":"123","author":"C Zamboglou","year":"2017","unstructured":"Zamboglou C, Sachpazidis I, Koubar K, Drendel V, Wiehle R, Kirste S, Mix M, Schiller F, Mavroidis P, Meyer PT, Werner M, Grosu AL, Baltas D (2017) Evaluation of intensity modulated radiation therapy dose painting for localized prostate cancer using (68)Ga-HBED-CC PSMA-PET\/CT: a planning study based on histopathology reference. Radiother Oncol 123:472\u2013477","journal-title":"Radiother Oncol"},{"key":"14_CR114","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s13014-018-1036-8","volume":"13","author":"C Zamboglou","year":"2018","unstructured":"Zamboglou C, Thomann B, Koubar K, Bronsert P, Krauss T, Rischke HC, Sachpazidis I, Drendel V, Salman N, Reichel K, Jilg CA, Werner M, Meyer PT, Bock M, Baltas D, Grosu AL (2018) Focal dose escalation for prostate cancer using (68)Ga-HBED-CC PSMA PET\/CT and MRI: a planning study based on histology reference. Radiat Oncol 13:81","journal-title":"Radiat Oncol"},{"key":"14_CR115","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1016\/j.ijrobp.2022.04.020","volume":"113","author":"C Zamboglou","year":"2022","unstructured":"Zamboglou C, Spohn SKB, Ruf J, Benndorf M, Gainey M, Kamps M, Jilg C, Gratzke C, Adebahr S, Schmidtmayer-Zamboglou B, Mix M, Bamberg F, Zschaeck S, Ghadjar P, Baltas D, Grosu AL (2022) PSMA-PET- and MRI-based focal dose escalated radiation therapy of primary prostate cancer: planned safety analysis of a nonrandomized 2-armed phase 2 trial (ARO2020-01). Int J Radiat Oncol Biol Phys 113:1025\u20131035","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"14_CR116","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2025.110883","volume":"208","author":"SKB Spohn","year":"2025","unstructured":"Spohn SKB, Zamboglou C, Burkle SL, Freitag MT, Brumberg J, Engel H, Gainey M, Kamps M, Toncheva P, Sprave T, Kirste S, Sigle A, Jilg C, Gratzke C, Adebahr S, Mix M, Bamberg F, Zschaeck S, Ghadjar P, Baltas D, Grosu AL (2025) Safety and quality of life of PSMA-PET- and MRI-based focal dose escalated radiotherapy for intermediate- and high-risk prostate cancer: primary endpoint analysis of the bi-centric phase II HypoFocal trial (ARO2020-01). Radiother Oncol 208:110883","journal-title":"Radiother Oncol"},{"key":"14_CR117","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1200\/JCO.20.02873","volume":"39","author":"LGW Kerkmeijer","year":"2021","unstructured":"Kerkmeijer LGW, Groen VH, Pos FJ, Haustermans K, Monninkhof EM, Smeenk RJ, Kunze-Busch M, de Boer JCJ, van der Voort van Zijp J, van Vulpen M, Draulans C, van den Bergh L, Isebaert S, van der Heide UA (2021) Focal boost to the intraprostatic tumor in external beam radiotherapy for patients with localized prostate cancer: results from the FLAME randomized phase III trial. J Clin Oncol 39:787\u2013796","journal-title":"J Clin Oncol"},{"key":"14_CR118","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2024.110568","volume":"201","author":"C Draulans","year":"2024","unstructured":"Draulans C, Haustermans K, Pos FJ, van der Heide UA, De Cock L, van der Voort van Zyp J, De Boer H, Smeenk RJ, Kunze-Busch M, Monninkhof EM, De Roover R, Isebaert S, Kerkmeijer LGW (2024) Stereotactic body radiotherapy with a focal boost to the intraprostatic tumor for intermediate and high risk prostate cancer: 5-year efficacy and toxicity in the hypo-FLAME trial. Radiother Oncol 201:110568","journal-title":"Radiother Oncol"},{"key":"14_CR119","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.ijrobp.2024.03.009","volume":"120","author":"B Yasar","year":"2024","unstructured":"Yasar B, Suh YE, Chapman E, Nicholls L, Henderson D, Jones C, Morrison K, Wells E, Henderson J, Meehan C, Sohaib A, Taylor H, Tree A, van As N (2024) Simultaneous focal boost with stereotactic radiation therapy for localized intermediate- to high-risk prostate cancer: primary outcomes of the SPARC phase 2 trial. Int J Radiat Oncol Biol Phys 120:49\u201358","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"14_CR120","doi-asserted-by":"publisher","first-page":"5795","DOI":"10.3390\/cancers13225795","volume":"13","author":"C Zamboglou","year":"2021","unstructured":"Zamboglou C, Spohn SKB, Adebahr S, Huber M, Kirste S, Sprave T, Gratzke C, Chen RC, Carl EG, Weber WA, Mix M, Benndorf M, Wiegel T, Baltas D, Jenkner C, Grosu AL (2021) PSMA-PET\/MRI-based focal dose escalation in patients with primary prostate cancer treated with stereotactic body radiation therapy (HypoFocal-SBRT): study protocol of a randomized, multicentric phase III trial. Cancers (Basel) 13:5795","journal-title":"Cancers (Basel)"},{"key":"14_CR121","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.crad.2007.05.022","volume":"63","author":"AM Hovels","year":"2008","unstructured":"Hovels AM, Heesakkers RA, Adang EM, Jager GJ, Strum S, Hoogeveen YL, Severens JL, Barentsz JO (2008) The diagnostic accuracy of CT and MRI in the staging of pelvic lymph nodes in patients with prostate cancer: a meta-analysis. Clin Radiol 63:387\u2013395","journal-title":"Clin Radiol"},{"key":"14_CR122","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.ejro.2015.11.004","volume":"3","author":"V Vallini","year":"2016","unstructured":"Vallini V, Ortori S, Boraschi P, Manassero F, Gabelloni M, Faggioni L, Selli C, Bartolozzi C (2016) Staging of pelvic lymph nodes in patients with prostate cancer: usefulness of multiple b value SE-EPI diffusion-weighted imaging on a 3.0 T MR system. Eur J Radiol Open 3:16\u201321","journal-title":"Eur J Radiol Open"},{"key":"14_CR123","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1111\/bju.13540","volume":"119","author":"PJ van Leeuwen","year":"2017","unstructured":"van Leeuwen PJ, Emmett L, Ho B, Delprado W, Ting F, Nguyen Q, Stricker PD (2017) Prospective evaluation of 68Gallium-prostate-specific membrane antigen positron emission tomography\/computed tomography for preoperative lymph node staging in prostate cancer. BJU Int 119:209\u2013215","journal-title":"BJU Int"},{"key":"14_CR124","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1016\/j.juro.2015.12.025","volume":"195","author":"T Maurer","year":"2016","unstructured":"Maurer T, Gschwend JE, Rauscher I, Souvatzoglou M, Haller B, Weirich G, Wester HJ, Heck M, Kubler H, Beer AJ, Schwaiger M, Eiber M (2016) Diagnostic efficacy of (68)Gallium-PSMA positron emission tomography compared to conventional imaging for lymph node staging of 130 consecutive patients with intermediate to high risk prostate cancer. J Urol 195:1436\u20131443","journal-title":"J Urol"},{"key":"14_CR125","doi-asserted-by":"publisher","first-page":"1806","DOI":"10.1007\/s00259-017-3752-y","volume":"44","author":"C Obek","year":"2017","unstructured":"Obek C, Doganca T, Demirci E, Ocak M, Kural AR, Yildirim A, Yucetas U, Demirdag C, Erdogan SM, Kabasakal L, Members of Urooncology Association T (2017) The accuracy of (68)Ga-PSMA PET\/CT in primary lymph node staging in high-risk prostate cancer. Eur J Nucl Med Mol Imaging 44:1806\u20131812","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"14_CR126","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1016\/S0140-6736(20)30314-7","volume":"395","author":"MS Hofman","year":"2020","unstructured":"Hofman MS, Lawrentschuk N, Francis RJ, Tang C, Vela I, Thomas P, Rutherford N, Martin JM, Frydenberg M, Shakher R, Wong LM, Taubman K, Ting Lee S, Hsiao E, Roach P, Nottage M, Kirkwood I, Hayne D, Link E, Marusic P, Matera A, Herschtal A, Iravani A, Hicks RJ, Williams S, Murphy DG, pro PSGC (2020) Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study. Lancet 395:1208\u20131216","journal-title":"Lancet"},{"key":"14_CR127","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.898774","volume":"12","author":"SKB Spohn","year":"2022","unstructured":"Spohn SKB, Birkenmaier V, Ruf J, Mix M, Sigle A, Haehl E, Adebahr S, Sprave T, Gkika E, Ruhle A, Nicolay NH, Kirste S, Grosu AL, Zamboglou C (2022) Risk factors for biochemical recurrence after PSMA-PET-guided definitive radiotherapy in patients with De Novo Lymph node-positive prostate cancer. Front Oncol 12:898774","journal-title":"Front Oncol"},{"key":"14_CR128","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1186\/1471-2407-14-202","volume":"14","author":"G Habl","year":"2014","unstructured":"Habl G, Hatiboglu G, Edler L, Uhl M, Krause S, Roethke M, Schlemmer HP, Hadaschik B, Debus J, Herfarth K (2014) Ion Prostate Irradiation (IPI) - a pilot study to establish the safety and feasibility of primary hypofractionated irradiation of the prostate with protons and carbon ions in a raster scan technique. BMC Cancer 14:202","journal-title":"BMC Cancer"},{"key":"14_CR129","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1186\/s13014-015-0548-8","volume":"10","author":"TP Shakespeare","year":"2015","unstructured":"Shakespeare TP (2015) Effect of prostate-specific membrane antigen positron emission tomography on the decision-making of radiation oncologists. Radiat Oncol 10:233","journal-title":"Radiat Oncol"},{"key":"14_CR130","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.eururo.2024.01.012","volume":"86","author":"WR Armstrong","year":"2024","unstructured":"Armstrong WR, Kishan AU, Booker KM, Grogan TR, Elashoff D, Lam EC, Clark KJ, Steinberg ML, Fendler WP, Hope TA, Nickols NG, Czernin J, Calais J (2024) Impact of prostate-specific membrane antigen positron emission tomography\/computed tomography on prostate cancer salvage radiotherapy management: results from a prospective multicenter randomized phase 3 trial (PSMA-SRT NCT03582774). Eur Urol 86:52\u201360","journal-title":"Eur Urol"},{"key":"14_CR131","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1001\/jamaoncol.2019.0096","volume":"5","author":"WP Fendler","year":"2019","unstructured":"Fendler WP, Calais J, Eiber M, Flavell RR, Mishoe A, Feng FY, Nguyen HG, Reiter RE, Rettig MB, Okamoto S, Emmett L, Zacho HD, Ilhan H, Wetter A, Rischpler C, Schoder H, Burger IA, Gartmann J, Smith R, Small EJ, Slavik R, Carroll PR, Herrmann K, Czernin J, Hope TA (2019) Assessment of 68Ga-PSMA-11 PET accuracy in localizing recurrent prostate cancer: a prospective single-arm clinical trial. JAMA Oncol 5:856\u2013863","journal-title":"JAMA Oncol"},{"key":"14_CR132","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s00259-015-3240-1","volume":"43","author":"FA Verburg","year":"2016","unstructured":"Verburg FA, Pfister D, Heidenreich A, Vogg A, Drude NI, Voo S, Mottaghy FM, Behrendt FF (2016) Extent of disease in recurrent prostate cancer determined by [(68)Ga]PSMA-HBED-CC PET\/CT in relation to PSA levels, PSA doubling time and Gleason score. Eur J Nucl Med Mol Imaging 43:397\u2013403","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"14_CR133","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1007\/s00259-017-3711-7","volume":"44","author":"A Afshar-Oromieh","year":"2017","unstructured":"Afshar-Oromieh A, Holland-Letz T, Giesel FL, Kratochwil C, Mier W, Haufe S, Debus N, Eder M, Eisenhut M, Schafer M, Neels O, Hohenfellner M, Kopka K, Kauczor HU, Debus J, Haberkorn U (2017) Diagnostic performance of (68)Ga-PSMA-11 (HBED-CC) PET\/CT in patients with recurrent prostate cancer: evaluation in 1007 patients. Eur J Nucl Med Mol Imaging 44:1258\u20131268","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"14_CR134","doi-asserted-by":"publisher","first-page":"2529","DOI":"10.1007\/s00259-023-06185-5","volume":"50","author":"N Solomonidou","year":"2023","unstructured":"Solomonidou N, Germanou D, Strouthos I, Karagiannis E, Farolfi A, Koerber SA, Debus J, Peeken JC, Vogel ME, Vrachimis A, Spohn SKB, Shelan M, Aebersold D, Grosu AL, Ceci F, Kroeze SGC, Guckenberger M, Fanti S, Belka C, Hruby G, Scharl S, Wiegel T, Bartenstein P, Henkenberens C, Emmett L, Schmidt-Hegemann NS, Ferentinos K, Zamboglou C (2023) PSMA-PET\/CT-guided salvage radiotherapy in recurrent or persistent prostate cancer and PSA < 0.2 ng\/ml. Eur J Nucl Med Mol Imaging 50:2529\u20132536","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"14_CR135","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2023.109678","volume":"184","author":"S Scharl","year":"2023","unstructured":"Scharl S, Zamboglou C, Strouthos I, Farolfi A, Serani F, Lanzafame H, Giuseppe Morganti A, Trapp C, Koerber SA, Debus J, Peeken JC, Vogel MME, Vrachimis A, Spohn SKB, Ruf J, Grosu AL, Ceci F, Fendler WP, Bartenstein P, Kroeze SGC, Guckenberger M, Krafcsik M, Klopscheck C, Fanti S, Hruby G, Emmett L, Belka C, Stief C, Schmidt-Hegemann NS, Henkenberens C, Mayer B, Miksch J, Shelan M, Aebersold DM, Thamm R, Wiegel T (2023) Salvage radiotherapy is effective in patients with PSMA-PET-negative biochemical recurrence- results of a retrospective study. Radiother Oncol 184:109678","journal-title":"Radiother Oncol"},{"key":"14_CR136","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1007\/s00259-023-06438-3","volume":"51","author":"S Adebahr","year":"2024","unstructured":"Adebahr S, Althaus A, Scharl S, Strouthos I, Farolfi A, Serani F, Lanzafame H, Trapp C, Koerber SA, Peeken JC, Vogel MME, Vrachimis A, Spohn SKB, Grosu AL, Kroeze SGC, Guckenberger M, Fanti S, Hruby G, Emmett L, Belka C, Schmidt-Hegemann NS, Henkenberens C, Aebersold DM, Wiegel T, Afshar-Oromieh A, Zamboglou C, Shelan M (2024) The prognostic significance of a negative PSMA-PET scan prior to salvage radiotherapy following radical prostatectomy. Eur J Nucl Med Mol Imaging 51:558\u2013567","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"14_CR137","unstructured":"EAU Guidelines on Prostate Cancer (2023\/2024)"},{"key":"14_CR138","doi-asserted-by":"publisher","first-page":"2537","DOI":"10.1007\/s00259-023-06195-3","volume":"50","author":"SKB Spohn","year":"2023","unstructured":"Spohn SKB, Schmidt-Hegemann NS, Ruf J, Mix M, Benndorf M, Bamberg F, Makowski MR, Kirste S, Ruhle A, Nouvel J, Sprave T, Vogel MME, Galitsnaya P, Gschwend JE, Gratzke C, Stief C, Lock S, Zwanenburg A, Trapp C, Bernhardt D, Nekolla SG, Li M, Belka C, Combs SE, Eiber M, Unterrainer L, Unterrainer M, Bartenstein P, Grosu AL, Zamboglou C, Peeken JC (2023) Development of PSMA-PET-guided CT-based radiomic signature to predict biochemical recurrence after salvage radiotherapy. Eur J Nucl Med Mol Imaging 50:2537\u20132547","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"14_CR139","doi-asserted-by":"publisher","first-page":"3281","DOI":"10.1200\/JCO.2006.09.2940","volume":"25","author":"FE Lecouvet","year":"2007","unstructured":"Lecouvet FE, Geukens D, Stainier A, Jamar F, Jamart J, d'Othee BJ, Therasse P, Vande Berg B, Tombal B (2007) Magnetic resonance imaging of the axial skeleton for detecting bone metastases in patients with high-risk prostate cancer: diagnostic and cost-effectiveness and comparison with current detection strategies. J Clin Oncol 25:3281\u20133287","journal-title":"J Clin Oncol"},{"key":"14_CR140","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.eururo.2017.03.042","volume":"73","author":"S Woo","year":"2018","unstructured":"Woo S, Suh CH, Kim SY, Cho JY, Kim SH (2018) Diagnostic performance of magnetic resonance imaging for the detection of bone metastasis in prostate cancer: a systematic review and meta-analysis. Eur Urol 73:81\u201391","journal-title":"Eur Urol"},{"key":"14_CR141","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1007\/s00259-016-3435-0","volume":"43","author":"T Pyka","year":"2016","unstructured":"Pyka T, Okamoto S, Dahlbender M, Tauber R, Retz M, Heck M, Tamaki N, Schwaiger M, Maurer T, Eiber M (2016) Comparison of bone scintigraphy and (68)Ga-PSMA PET for skeletal staging in prostate cancer. Eur J Nucl Med Mol Imaging 43:2114\u20132121","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"14_CR142","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.736654","volume":"11","author":"F Liu","year":"2021","unstructured":"Liu F, Dong J, Shen Y, Yun C, Wang R, Wang G, Tan J, Wang T, Yao Q, Wang B, Li L, Mi J, Zhou D, Xiong F (2021) Comparison of PET\/CT and MRI in the diagnosis of bone metastasis in prostate cancer patients: a network analysis of diagnostic studies. Front Oncol 11:736654","journal-title":"Front Oncol"},{"key":"14_CR143","doi-asserted-by":"publisher","first-page":"223","DOI":"10.2967\/jnumed.124.268275","volume":"66","author":"C Madsen","year":"2025","unstructured":"Madsen C, Fuglo D, Pedersen M, Broholm R, Ostergren PB, Bisbjerg R, Kongsted P, Nielsen K, Haarmark C, Zacho H (2025) Prospective head-to-head comparison of (18)F-PSMA PET\/CT and (18)F-NaF PET\/CT for assessing bone metastases in 160 patients with newly diagnosed high-risk prostate cancer. J Nucl Med 66:223\u2013229","journal-title":"J Nucl Med"},{"key":"14_CR144","doi-asserted-by":"publisher","first-page":"64","DOI":"10.6004\/jnccn.2019.0001","volume":"17","author":"WJ Koh","year":"2019","unstructured":"Koh WJ, Abu-Rustum NR, Bean S, Bradley K, Campos SM, Cho KR, Chon HS, Chu C, Clark R, Cohn D, Crispens MA, Damast S, Dorigo O, Eifel PJ, Fisher CM, Frederick P, Gaffney DK, Han E, Huh WK, Lurain JR, Mariani A, Mutch D, Nagel C, Nekhlyudov L, Fader AN, Remmenga SW, Reynolds RK, Tillmanns T, Ueda S, Wyse E, Yashar CM, McMillian NR, Scavone JL (2019) Cervical cancer, Version 3.2019, NCCN clinical practice guidelines in oncology. J Natl Compr Cancer Netw 17:64\u201384","journal-title":"J Natl Compr Cancer Netw"},{"key":"14_CR145","doi-asserted-by":"publisher","first-page":"iv72\u2013iv83","DOI":"10.1093\/annonc\/mdx220","volume":"28","author":"C Marth","year":"2017","unstructured":"Marth C, Landoni F, Mahner S, McCormack M, Gonzalez-Martin A, Colombo N, Committee EG (2017) Cervical cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 28:iv72\u2013iv83","journal-title":"Ann Oncol"},{"key":"14_CR146","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.ygyno.2004.12.007","volume":"97","author":"LJ Havrilesky","year":"2005","unstructured":"Havrilesky LJ, Kulasingam SL, Matchar DB, Myers ER (2005) FDG-PET for management of cervical and ovarian cancer. Gynecol Oncol 97:183\u2013191","journal-title":"Gynecol Oncol"},{"key":"14_CR147","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1016\/j.ijrobp.2009.06.041","volume":"77","author":"EA Kidd","year":"2010","unstructured":"Kidd EA, Siegel BA, Dehdashti F, Rader JS, Mutic S, Mutch DG, Powell MA, Grigsby PW (2010) Clinical outcomes of definitive intensity-modulated radiation therapy with fluorodeoxyglucose-positron emission tomography simulation in patients with locally advanced cervical cancer. Int J Radiat Oncol Biol Phys 77:1085\u20131091","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"14_CR148","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1016\/j.ijrobp.2003.12.038","volume":"59","author":"PW Grigsby","year":"2004","unstructured":"Grigsby PW, Singh AK, Siegel BA, Dehdashti F, Rader J, Zoberi I (2004) Lymph node control in cervical cancer. Int J Radiat Oncol Biol Phys 59:706\u2013712","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"14_CR149","doi-asserted-by":"publisher","first-page":"170","DOI":"10.6004\/jnccn.2018.0006","volume":"16","author":"WJ Koh","year":"2018","unstructured":"Koh WJ, Abu-Rustum NR, Bean S, Bradley K, Campos SM, Cho KR, Chon HS, Chu C, Cohn D, Crispens MA, Damast S, Dorigo O, Eifel PJ, Fisher CM, Frederick P, Gaffney DK, George S, Han E, Higgins S, Huh WK, Lurain JR 3rd, Mariani A, Mutch D, Nagel C, Nekhlyudov L, Fader AN, Remmenga SW, Reynolds RK, Tillmanns T, Ueda S, Wyse E, Yashar CM, McMillian NR, Scavone JL (2018) Uterine neoplasms, Version 1.2018, NCCN clinical practice guidelines in oncology. J Natl Compr Cancer Netw 16:170\u2013199","journal-title":"J Natl Compr Cancer Netw"},{"key":"14_CR150","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.ygyno.2012.11.025","volume":"128","author":"SL Antonsen","year":"2013","unstructured":"Antonsen SL, Jensen LN, Loft A, Berthelsen AK, Costa J, Tabor A, Qvist I, Hansen MR, Fisker R, Andersen ES, Sperling L, Nielsen AL, Asmussen J, Hogdall E, Fago-Olsen CL, Christensen IJ, Nedergaard L, Jochumsen K, Hogdall C (2013) MRI, PET\/CT and ultrasound in the preoperative staging of endometrial cancer - a multicenter prospective comparative study. Gynecol Oncol 128:300\u2013308","journal-title":"Gynecol Oncol"},{"key":"14_CR151","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.ygyno.2013.05.011","volume":"130","author":"C Crivellaro","year":"2013","unstructured":"Crivellaro C, Signorelli M, Guerra L, De Ponti E, Pirovano C, Fruscio R, Elisei F, Montanelli L, Buda A, Messa C (2013) Tailoring systematic lymphadenectomy in high-risk clinical early stage endometrial cancer: the role of 18F-FDG PET\/CT. Gynecol Oncol 130:306\u2013311","journal-title":"Gynecol Oncol"},{"key":"14_CR152","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.2967\/jnumed.115.159913","volume":"56","author":"JA Husby","year":"2015","unstructured":"Husby JA, Reitan BC, Biermann M, Trovik J, Bjorge L, Magnussen IJ, Salvesen OO, Salvesen HB, Haldorsen IS (2015) Metabolic tumor volume on 18F-FDG PET\/CT improves preoperative identification of high-risk endometrial carcinoma patients. J Nucl Med 56:1191\u20131198","journal-title":"J Nucl Med"},{"key":"14_CR153","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1097\/RLU.0000000000000852","volume":"40","author":"M Signorelli","year":"2015","unstructured":"Signorelli M, Crivellaro C, Buda A, Guerra L, Fruscio R, Elisei F, Dolci C, Cuzzocrea M, Milani R, Messa C (2015) Staging of high-risk endometrial cancer with PET\/CT and sentinel lymph node mapping. Clin Nucl Med 40:780\u2013785","journal-title":"Clin Nucl Med"},{"key":"14_CR154","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1186\/s12885-025-14392-6","volume":"25","author":"X Li","year":"2025","unstructured":"Li X, Shi W, Zhang Q, Lin X, Sun H (2025) A radiogenomics study on (18)F-FDG PET\/CT in endometrial cancer by a novel deep learning segmentation algorithm. BMC Cancer 25:1006","journal-title":"BMC Cancer"}],"container-title":["Recent Results in Cancer Research","Molecular Imaging in Oncology - Volume 2"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-032-21415-7_14","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T11:02:40Z","timestamp":1779361360000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-032-21415-7_14"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"ISBN":["9783032214140","9783032214157"],"references-count":152,"URL":"https:\/\/doi.org\/10.1007\/978-3-032-21415-7_14","relation":{},"ISSN":["0080-0015","2197-6767"],"issn-type":[{"value":"0080-0015","type":"print"},{"value":"2197-6767","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"22 May 2026","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}